Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Trial to Evaluate How Therapeutic Drug Monitoring of Protease Inhibitors Increases Virologic Success and Tolerance of HAART (ANRS 111 COPHAR2)

NCT00122590 is registered in ClinicalTrials.gov with French National Agency for Research on AIDS and Viral Hepatitis as lead sponsor.

NCT NCT00122590
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00122590 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Trial to Evaluate How Therapeutic Drug Monitoring of Protease Inhibitors Increases Virologic Success and Tolerance of HAART (ANRS 111 COPHAR2)
Lead sponsor
French National Agency for Research on AIDS and Viral Hepatitis
Phase
Not applicable
Overall status
Terminated
Start date
July 31, 2002
Completion date
March 31, 2005
Enrollment
115
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections